Latest Insider Transactions at Harpoon Therapeutics, Inc. (HARP)
This section provides a real-time view of insider transactions for Harpoon Therapeutics, Inc. (HARP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Harpoon Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Harpoon Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Ronald Hunt |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$10,000,000
$1000.0 P/Share
|
|
Sep 22
2021
|
Georgia Erbez Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
10,300
+34.9%
|
$82,400
$8.1 P/Share
|
|
Jul 01
2021
|
Holger Wesche Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-15.91%
|
$140,000
$14.0 P/Share
|
|
Jul 01
2021
|
Holger Wesche Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+13.73%
|
$0
$0.6 P/Share
|
|
Jun 02
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,118
-0.4%
|
$502,360
$20.5 P/Share
|
|
Jun 01
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,491
-0.29%
|
$369,820
$20.44 P/Share
|
|
May 28
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,885
-0.07%
|
$291,585
$21.8 P/Share
|
|
May 27
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,961
-0.22%
|
$279,220
$20.26 P/Share
|
|
May 26
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,198
-0.05%
|
$63,960
$20.04 P/Share
|
|
May 24
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,000
-0.08%
|
$100,000
$20.12 P/Share
|
|
May 21
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,907
-0.17%
|
$218,140
$20.21 P/Share
|
|
May 20
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,713
-0.18%
|
$234,260
$20.34 P/Share
|
|
May 19
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,833
-0.28%
|
$356,660
$20.39 P/Share
|
|
May 18
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,402
-0.28%
|
$368,040
$20.67 P/Share
|
|
May 17
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,666
-0.07%
|
$93,320
$20.07 P/Share
|
|
May 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,900
-0.11%
|
$138,000
$20.04 P/Share
|
|
May 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,855
-0.07%
|
$97,100
$20.06 P/Share
|
|
May 12
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,684
-0.46%
|
$593,680
$20.53 P/Share
|
|
May 11
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
21,445
-0.16%
|
$450,345
$21.24 P/Share
|
|
May 10
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
17,133
-0.13%
|
$376,926
$22.12 P/Share
|
|
May 05
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,172
-0.08%
|
$223,784
$22.81 P/Share
|
|
May 04
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,730
-0.23%
|
$683,790
$23.18 P/Share
|
|
May 03
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,766
-0.23%
|
$707,618
$23.24 P/Share
|
|
Apr 30
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
268,023
-3.89%
|
$5,896,506
$22.35 P/Share
|
|
Apr 29
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
67,292
-0.48%
|
$1,480,424
$22.28 P/Share
|
|
Apr 28
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
51,022
-0.36%
|
$1,071,462
$21.83 P/Share
|
|
Apr 27
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,829
-0.08%
|
$248,409
$21.13 P/Share
|
|
Apr 21
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,972
-0.06%
|
$170,468
$19.21 P/Share
|
|
Apr 20
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,249
-0.16%
|
$400,482
$18.9 P/Share
|
|
Apr 19
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,056
-0.07%
|
$191,064
$19.69 P/Share
|
|
Apr 16
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,847
-0.04%
|
$116,940
$20.19 P/Share
|
|
Apr 15
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
1,052
-0.03%
|
$21,040
$20.49 P/Share
|
|
Apr 15
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,696
-0.12%
|
$173,920
$20.49 P/Share
|
|
Apr 14
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
1,671
-0.03%
|
$33,420
$20.45 P/Share
|
|
Apr 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,806
-0.1%
|
$276,120
$20.45 P/Share
|
|
Apr 13
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
1,943
-0.03%
|
$36,917
$19.72 P/Share
|
|
Apr 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,054
-0.11%
|
$305,026
$19.72 P/Share
|
|
Apr 12
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
2,496
-0.03%
|
$52,416
$21.64 P/Share
|
|
Apr 12
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,628
-0.1%
|
$433,188
$21.64 P/Share
|
|
Apr 09
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
10,300
-0.32%
|
$236,900
$23.67 P/Share
|
|
Apr 09
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,300
-0.14%
|
$236,900
$23.67 P/Share
|
|
Apr 01
2021
|
Holger Wesche Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.03%
|
$200,000
$20.78 P/Share
|
|
Apr 01
2021
|
Holger Wesche Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.26%
|
$0
$0.6 P/Share
|
|
Feb 17
2021
|
Georgia Erbez Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.7%
|
$50,000
$2.12 P/Share
|
|
Feb 10
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
183,051
-5.35%
|
$3,661,020
$20.0 P/Share
|
|
Feb 09
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
9,400
-0.27%
|
$188,000
$20.25 P/Share
|
|
Feb 08
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
72,128
-2.06%
|
$1,442,560
$20.04 P/Share
|
|
Feb 05
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
10,172
-0.29%
|
$203,440
$20.01 P/Share
|
|
Feb 04
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
29,730
-0.84%
|
$594,600
$20.37 P/Share
|
|
Feb 03
2021
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect |
41,922
-1.17%
|
$838,440
$20.21 P/Share
|